×
About 24,102 results

ALLMedicine™ Severe Acute Respiratory Syndrome Center

Research & Reviews  11,499 results

Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers.
https://doi.org/10.1080/14767058.2021.1892637
The Journal of Maternal-fetal & Neonatal Medicine : the O... Zhang P, Heyman T et. al.

Mar 1st, 2021 - COVID19 is caused by a newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that affects pregnant women equally to the general population. How SARS-CoV2 affects the mothers, the neonates and the placental pathology remain c...

Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19.
https://doi.org/10.1080/23744235.2021.1890331
Infectious Diseases (London, England); Viceconte G, Buonomo AR et. al.

Mar 1st, 2021 - Several cases of invasive fungal diseases in patients with COVID-19 have been reported, mostly due to Aspergillus spp., with anecdotic reports of Pneumocystis jirovecii pneumonia (PJP) as co-infections in immunocompromised patients. We describe th...

COVID-19: Potential Repurposing Drugs.
https://doi.org/10.2174/1871526521666210301143441
Infectious Disorders Drug Targets; Leowattana W

Mar 1st, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the most infectious diseases and caused coronavirus disease in 2019 (COVID-19). It has been widely spread worldwide and infected more than 28 million peoples in 215 countries, ...

Sex-based differences in severity and mortality in COVID-19.
https://doi.org/10.1002/rmv.2223
Reviews in Medical Virology; Alwani M, Yassin A et. al.

Mar 1st, 2021 - The current coronavirus disease (COVID-19) pandemic caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a male bias in severity and mortality. This is consistent with previous coronavirus pandemics such as SARS-CoV and...

see more →

Guidelines  225 results

FDA Briefing Document: Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19
https://www.fda.gov/media/146217/download
Vaccines and Related Biological Products Advisory Committee Meeting

Feb 25th, 2021 - On February 4, 2021, Janssen Biotech, Inc. (the Sponsor) submitted an Emergency Use Authorization (EUA) request to FDA for an investigational vaccine intended to prevent COVID19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2021801
The New England Journal of Medicine; Mitjà O, Corbacho-Monné M et. al.

Feb 2nd, 2021 - Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy to prevent coronavirus disease 2...

Setting the criteria for SARS-CoV-2 reinfection – six possible cases
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422822/
The Journal of Infection; Tomassini S, Kotecha D et. al.

Jan 31st, 2021 - We read with interest the article by Batisse et al.1 describing 11 possible cases of symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfection. However, the intervening period of ‘clinical cure’ was not confirmed by a ne...

Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic
https://www.acpjournals.org/doi/10.7326/M20-7918
Annals of Internal Medicine; Perez J, Roustit M et. al.

Jan 25th, 2021 - Background: A few weeks after the beginning of the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uncontrolled trials and in vitro studies suggested that chloroquine and hydroxychloroquine may have efficacy in treating c...

Comparison of three commercial SARS‐CoV‐2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics
https://onlinelibrary.wiley.com/doi/10.1002/jmv.26764
Journal of Medical Virology; Ho, Y.I. et. al.

Jan 10th, 2021 - To the Editor, Various studies have demonstrated that deep throat saliva (DTS) is comparable with nasopharyngeal (NP) specimens for detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by real‐time polymerase chain reaction.1...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  11,857 results

Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers.
https://doi.org/10.1080/14767058.2021.1892637
The Journal of Maternal-fetal & Neonatal Medicine : the O... Zhang P, Heyman T et. al.

Mar 1st, 2021 - COVID19 is caused by a newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that affects pregnant women equally to the general population. How SARS-CoV2 affects the mothers, the neonates and the placental pathology remain c...

Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19.
https://doi.org/10.1080/23744235.2021.1890331
Infectious Diseases (London, England); Viceconte G, Buonomo AR et. al.

Mar 1st, 2021 - Several cases of invasive fungal diseases in patients with COVID-19 have been reported, mostly due to Aspergillus spp., with anecdotic reports of Pneumocystis jirovecii pneumonia (PJP) as co-infections in immunocompromised patients. We describe th...

COVID-19: Potential Repurposing Drugs.
https://doi.org/10.2174/1871526521666210301143441
Infectious Disorders Drug Targets; Leowattana W

Mar 1st, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the most infectious diseases and caused coronavirus disease in 2019 (COVID-19). It has been widely spread worldwide and infected more than 28 million peoples in 215 countries, ...

Sex-based differences in severity and mortality in COVID-19.
https://doi.org/10.1002/rmv.2223
Reviews in Medical Virology; Alwani M, Yassin A et. al.

Mar 1st, 2021 - The current coronavirus disease (COVID-19) pandemic caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a male bias in severity and mortality. This is consistent with previous coronavirus pandemics such as SARS-CoV and...

see more →

News  513 results

FDA Briefing Document: Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19
https://www.fda.gov/media/146217/download
Vaccines and Related Biological Products Advisory Committee Meeting

Feb 25th, 2021 - On February 4, 2021, Janssen Biotech, Inc. (the Sponsor) submitted an Emergency Use Authorization (EUA) request to FDA for an investigational vaccine intended to prevent COVID19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2021801
The New England Journal of Medicine; Mitjà O, Corbacho-Monné M et. al.

Feb 2nd, 2021 - Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy to prevent coronavirus disease 2...

Setting the criteria for SARS-CoV-2 reinfection – six possible cases
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422822/
The Journal of Infection; Tomassini S, Kotecha D et. al.

Jan 31st, 2021 - We read with interest the article by Batisse et al.1 describing 11 possible cases of symptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) reinfection. However, the intervening period of ‘clinical cure’ was not confirmed by a ne...

Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic
https://www.acpjournals.org/doi/10.7326/M20-7918
Annals of Internal Medicine; Perez J, Roustit M et. al.

Jan 25th, 2021 - Background: A few weeks after the beginning of the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uncontrolled trials and in vitro studies suggested that chloroquine and hydroxychloroquine may have efficacy in treating c...

Comparison of three commercial SARS‐CoV‐2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics
https://onlinelibrary.wiley.com/doi/10.1002/jmv.26764
Journal of Medical Virology; Ho, Y.I. et. al.

Jan 10th, 2021 - To the Editor, Various studies have demonstrated that deep throat saliva (DTS) is comparable with nasopharyngeal (NP) specimens for detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by real‐time polymerase chain reaction.1...

see more →

Patient Education  7 results see all →